Search

everythinglearnresearchcommunity

for

Search:↓

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Different types of scarring alopecia may be stages of one disease, and accurate diagnosis is crucial to prevent permanent hair loss.

Pseudopelade of Brocq is hard to diagnose and treat, with limited effective options.

Dermoscopy is useful for tracking alopecia areata treatment, with yellow dots and new vellus hairs being good indicators of hair regrowth.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

Levetiracetam may cause hair loss, which can potentially reverse with lower doses or stopping the drug.

Stopping isoniazid can reverse hair loss caused by the drug.

The document concludes that early diagnosis is key for treating common baldness in women, but reassurance is often the best approach as hair thinning can be a normal part of aging.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.